GlobeMed
Non-Profit & Charitable Organizations · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 Sherman Ave Ste 3-0, Evanston, Illi...Phone Number
(847) 786-5716Website
www.globemed.orgRevenue
$6 MillionIndustry
About GlobeMed
About GlobeMed and ASPAT-Per: GlobeMed at the University of Chicago is a student-run organization that is engaged in a long-term partnership with the Asociación de Personas Afectadas por Tuberculosis del Per, a community-based health organization for TB patients that fights to end discrimination against the disease and expand patient access to treatment. Together, they develop and fund projects that empower patients to recover from TB in a prompt and dignified manner with the broader aim of eliminating social stigma against the contraction, diagnosis, and prevention of tuberculosis. These projects include modular housing, micro-business seminars, food baskets, seed funding for TB patients, and an upcoming breakfast program that offsets the negative side effects of TB regimens and incentivizes the continuation of treatment.Explore more
SIC Code 83,839NAICS Code 81,813Show moreGlobeMed Org Chart
Compare Similar Companies to GlobeMed
Compare insights from companies similar to GlobeMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2001
GlobeMed Tech Stack
A closer look at the technologies used by GlobeMed
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GlobeMed
Sign Up For FreeTo access detailed company insights
About GlobeMed and ASPAT-Per: GlobeMed at the University of Chicago is a student-run organization that is engaged in a long-term partnership with the Asociación de Personas Afectadas por Tuberculosis del Per, a community-based health organization for TB patients that fights to end discrimination against the disease and expand patient access to trea... Read More